Known targets — ChEMBL curated mechanism
ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4
The experimentally established mechanism targets of Emoxypine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | HPGD | P15428 | 4/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.38 |
| ▸ | GABRP | O00591 | 1/20 | 0.38 |
| ▸ | GABRD | O14764 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.38 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Emoxypine SCHEMBL30182715 | 1.00 | KDM4E (0.56) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL195347 | 0.87 | KDM4E (0.72) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL29362452 | 0.87 | KDM4E (0.72) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL1373708 | 0.85 | KDM4E (0.69) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL11089142 | 0.85 | KDM4E (0.69) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL31074958 | 0.85 | KDM4E (0.69) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL1373711 | 0.83 | KDM4E (0.67) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL26983696 | 0.83 | KDM4E (0.67) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL21061700 | 0.83 | KDM4E (0.73) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL30377215 | 0.81 | KDM4E (0.47) | KDM4EALDH1A1HPGDHSD17B10USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021242136-A1 | DRUG FOR A COMBINATION THERAPY FOR DISEASES CAUSED BY BETACORONAVIRUSES | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НАУЧНО-ПРОИЗВОДСТВЕННАЯ КОМПАНИЯ "ФАРМАСОФТ" | 2021-12-02 | — | — | WO | claimed |
| WO-2021118403-A1 | SYSTEM FOR DELIVERING 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR PERORAL ADMINISTRATION | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НАУЧНО-ПРОИЗВОДСТВЕННАЯ КОМПАНИЯ "ФАРМАСОФТ" | 2021-06-17 | — | — | WO | claimed |
| WO-2025023864-A1 | METHOD FOR TREATING TRAUMATIC BRAIN INJURY AND DRUG FOR CARRYING OUT SAID METHOD | Федеральное государственное бюджетное научное учреждение "Федеральный исследовательский центр фундаментальной и трансляционной медицины" (ФИЦ ФТМ) | 2025-01-30 | — | — | WO | disclosed |
| WO-2022055397-A1 | METHOD FOR PRODUCING A DRUG FOR PARENTERAL ADMINISTRATION | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НАУЧНО-ТЕХНОЛОГИЧЕСКАЯ ФАРМАЦЕВТИЧЕСКАЯ ФИРМА "ПОЛИСАН" | 2022-03-17 | — | — | WO | disclosed |
| WO-2021242136-A1 | DRUG FOR A COMBINATION THERAPY FOR DISEASES CAUSED BY BETACORONAVIRUSES | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НАУЧНО-ПРОИЗВОДСТВЕННАЯ КОМПАНИЯ "ФАРМАСОФТ" | 2021-12-02 | — | — | WO | disclosed |
| WO-2021242136-A1 | DRUG FOR A COMBINATION THERAPY FOR DISEASES CAUSED BY BETACORONAVIRUSES | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НАУЧНО-ПРОИЗВОДСТВЕННАЯ КОМПАНИЯ "ФАРМАСОФТ" | 2021-12-02 | — | — | WO | disclosed |
| WO-2021118403-A1 | SYSTEM FOR DELIVERING 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR PERORAL ADMINISTRATION | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НАУЧНО-ПРОИЗВОДСТВЕННАЯ КОМПАНИЯ "ФАРМАСОФТ" | 2021-06-17 | — | — | WO | disclosed |
| WO-2021118403-A1 | SYSTEM FOR DELIVERING 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR PERORAL ADMINISTRATION | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НАУЧНО-ПРОИЗВОДСТВЕННАЯ КОМПАНИЯ "ФАРМАСОФТ" | 2021-06-17 | — | — | WO | disclosed |
| WO-2019117820-A1 | L-ENANTIOMER 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM L-HYDROXYBUTANDIOATE WITH CEREBROPROTECTIVE, HEPATOPROTECTIVE, LIPID-REGULATING, ANTI-ISCHEMIC AND NEUROTROPIC ACTIVITIES | MADMIT TRADE, A. S. (SK) | 2019-06-20 | — | — | WO | disclosed |
| WO-2014070038-A1 | SOLID DOSAGE FORM HAVING NEUROPROTECTIVE, ANTIAMNESIC, ANTIOXIDANT, ANTIHYPOXIC AND ANTI-ISCHEMIC ACTIVITY (VARIANTS) | LOBKO VLADIMIR PAVLOVICH (RU) | 2014-05-08 | — | — | WO | disclosed |
| WO-2014012593-A1 | ALKYL SUBSTITUTED 3-HYDROXYPYRIDINES FOR THE TREATMENT OF DEPRESSION | HandelsOrt AG (CH) | 2014-01-23 | — | — | WO | disclosed |
| WO-2013129977-A2 | PHARMACEUTICAL COMPOSITION FOR INJECTIONS HAVING NEUROPROTECTOR, ANTIAMNAESIC, ANTIOXIDANT, ANTIHYPOXIC AND ANTIISCHAEMIC ACTIVITY (EMBODIMENTS) | LOBKO VLADIMIR PAVLOVICH (RU) | 2013-09-06 | — | — | WO | disclosed |
| EP-1878431-B1 | MEDICINAL AGENT FOR PREVENTING PROGRESSION OF APOPTOTIC AND JUGULATING NECROTIC CHANGES IN THE ORGANISM TISSUES | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU N PROIZV KOMPANIA FARMASOFT (RU) | 2011-04-06 | — | — | EP | disclosed |
| EP-1789026-B1 | METHOD FOR SYSTEMIC BIO-CORRECTION OF AN ORGANISM | INST MOLEKULAR UND (DE) | 2011-01-05 | — | — | EP | disclosed |
| EP-1878431-A1 | MEDICINAL AGENT FOR PREVENTING PROGRESSION OF APOPTOTIC AND JUGULATING NECROTIC CHANGES IN THE ORGANISM TISSUES | Sukoyan, Galina Victorovna (RU) | 2008-01-16 | — | — | EP | disclosed |
| EP-1789026-A2 | METHOD FOR SYSTEMIC BIO-CORRECTION OF AN ORGANISM | Institut für Molekular und (DE) | 2007-05-30 | — | — | EP | disclosed |
| WO-2006007818-A2 | METHOD FOR SYSTEMIC BIO-CORRECTION OF AN ORGANISM | INSTITUT FÜR MOLEKULAR- UND SYSTEM-MEDIZIN (DE) | 2006-01-26 | — | — | WO | disclosed |
| EP-1380310-A1 | Wound dressing | Filatov, Vladimir N. (RU) | 2004-01-14 | — | — | EP | disclosed |
| US-6500799-B2 | Wound dressing | FILATOV VLADIMIR N (RU) | 2002-12-31 | — | — | US | disclosed |
| US-20020012692-A1 | Wound dressing | FILATOV VLADIMIR N (RU) | 2002-01-31 | — | — | US | disclosed |